Cytokinetics | CYTK - Bienes





Bienes Cambio Fecha
Acadia Pharmaceuticals USD 1.74B 137.67M 2026-06
Amgen USD 95.64B 3.14B 2026-06
Arca Biopharma USD 1.14B 634.91M 2026-06
Bayer EUR 107.29B 659M 2026-06
Biogen USD 32.09B 2.6B 2026-06
Brainstorm Cell Therapeutics USD 788K 33K 2026-06
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Capricor Therapeutics USD 368.74M 42.45M 2026-06
Cytokinetics USD 1.92B 651.07M 2026-06
Eisai JPY 1.56T 108.98B 2026-06
Eli Lilly USD 142.28B 25.71B 2026-06
Exelixis USD 2.49B 99.36M 2026-06
Geron USD 519.01M 15.11M 2026-06
Halozyme Therapeutics USD 2.58B 95.31M 2026-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
Ligand Pharmaceuticals USD 2.19B 653.77M 2026-06
Merck USD 129.8B 1.12B 2026-06
Novartis USD 122.03B 3.5B 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Regeneron Pharmaceuticals USD 41.73B 861.8M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 129.06B 1.04B 2026-06